https://ddn.pluspedia.org/w/index.php?action=history&feed=atom&title=Hepatitis_C 2026-08-13T09:13:27Z Versionsgeschichte dieser Seite in PlusPedia MediaWiki 1.43.3 https://ddn.pluspedia.org/w/index.php?title=Hepatitis_C&diff=722114&oldid=prev 2020-11-22T20:41:56Z

<p>genauer</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 22. November 2020, 20:41 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&#039;&#039;&#039;Hepatitis C&#039;&#039;&#039; ist eine durch das [[Hepatitis-C-Virus]] verursachte [[Infektionskrankheit]] beim Menschen. Sie zeichnet sich durch eine hohe Rate bei [[chronische Krankheit|chronischen Krankheitsverlauf]] aus (bis 80 %), die im Verlauf zu schweren [[Leber]]schädigungen wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. Die freien Übersichtsartikel zeigen 10 Jahre Forschungsgeschichte.&lt;ref name=&quot;PMID15084065&quot;&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name=&quot;PMID15084064&quot;&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name=&quot;PMID18519925&quot;&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name=&quot;PMID8849151&quot;&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name=&quot;PMID16923861&quot;&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name=&quot;PMID19129320&quot;&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name=&quot;PMID17699464&quot;&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name=&quot;PMID17047105&quot;&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name=&quot;PMID16905701&quot;&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name=&quot;PMID16849345&quot;&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name=&quot;PMID11413125&quot;&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name=&quot;PMID9691933&quot;&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name=&quot;PMID19034865&quot;&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name=&quot;PMID10904508&quot;&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name=&quot;PMID9690235&quot;&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name=&quot;PMID17478492&quot;&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name=&quot;PMID11261704&quot;&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name=&quot;PMID11261703&quot;&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name=&quot;PMID11261701&quot;&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name=&quot;PMID11261700&quot;&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name=&quot;PMID11261698&quot;&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name=&quot;PMID11261697&quot;&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name=&quot;PMID11261696&quot;&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name=&quot;PMID15937203&quot;&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name=&quot;PMID17317717&quot;&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name=&quot;PMID12730523&quot;&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name=&quot;PMID11584690&quot;&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name=&quot;PMID1656611&quot;&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name=&quot;PMID17552031&quot;&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name=&quot;PMID17552030&quot;&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name=&quot;PMID17552023&quot;&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name=&quot;PMID18972443&quot;&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name=&quot;PMID18972442&quot;&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name=&quot;PMID18240152&quot;&gt;Hepatitis C genotype 4: What we know and what we don&#039;t yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name=&quot;PMID16941688&quot;&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name=&quot;PMID16799966&quot;&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name=&quot;PMID16149085&quot;&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name=&quot;PMID15057920&quot;&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name=&quot;PMID14752815&quot;&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name=&quot;PMID12829979&quot;&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name=&quot;PMID12407599&quot;&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name=&quot;PMID12407590&quot;&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name=&quot;PMID12407589&quot;&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name=&quot;PMID12407588&quot;&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name=&quot;PMID12407587&quot;&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name=&quot;PMID12407578&quot;&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name=&quot;PMID12407575&quot;&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name=&quot;PMID11172332&quot;&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name=&quot;PMID10733560&quot;&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name=&quot;PMID9305659&quot;&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name=&quot;PMID9185778&quot;&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name=&quot;PMID7853784&quot;&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&#039;&#039;&#039;Hepatitis C&#039;&#039;&#039; ist eine durch das [[Hepatitis-C-Virus]] verursachte [[Infektionskrankheit]] beim Menschen. Sie zeichnet sich durch eine hohe Rate bei [[chronische Krankheit|chronischen Krankheitsverlauf]] aus (bis 80 %), die im Verlauf zu schweren [[Leber]]schädigungen wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. Die freien Übersichtsartikel zeigen 10 Jahre Forschungsgeschichte.&lt;ref name=&quot;PMID15084065&quot;&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name=&quot;PMID15084064&quot;&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name=&quot;PMID18519925&quot;&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name=&quot;PMID8849151&quot;&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name=&quot;PMID16923861&quot;&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name=&quot;PMID19129320&quot;&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name=&quot;PMID17699464&quot;&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name=&quot;PMID17047105&quot;&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name=&quot;PMID16905701&quot;&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name=&quot;PMID16849345&quot;&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name=&quot;PMID11413125&quot;&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name=&quot;PMID9691933&quot;&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name=&quot;PMID19034865&quot;&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name=&quot;PMID10904508&quot;&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name=&quot;PMID9690235&quot;&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name=&quot;PMID17478492&quot;&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name=&quot;PMID11261704&quot;&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name=&quot;PMID11261703&quot;&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name=&quot;PMID11261701&quot;&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name=&quot;PMID11261700&quot;&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name=&quot;PMID11261698&quot;&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name=&quot;PMID11261697&quot;&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name=&quot;PMID11261696&quot;&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name=&quot;PMID15937203&quot;&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name=&quot;PMID17317717&quot;&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name=&quot;PMID12730523&quot;&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name=&quot;PMID11584690&quot;&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name=&quot;PMID1656611&quot;&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name=&quot;PMID17552031&quot;&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name=&quot;PMID17552030&quot;&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name=&quot;PMID17552023&quot;&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name=&quot;PMID18972443&quot;&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name=&quot;PMID18972442&quot;&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name=&quot;PMID18240152&quot;&gt;Hepatitis C genotype 4: What we know and what we don&#039;t yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name=&quot;PMID16941688&quot;&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name=&quot;PMID16799966&quot;&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name=&quot;PMID16149085&quot;&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name=&quot;PMID15057920&quot;&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name=&quot;PMID14752815&quot;&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name=&quot;PMID12829979&quot;&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name=&quot;PMID12407599&quot;&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name=&quot;PMID12407590&quot;&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name=&quot;PMID12407589&quot;&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name=&quot;PMID12407588&quot;&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name=&quot;PMID12407587&quot;&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name=&quot;PMID12407578&quot;&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name=&quot;PMID12407575&quot;&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name=&quot;PMID11172332&quot;&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name=&quot;PMID10733560&quot;&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name=&quot;PMID9305659&quot;&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name=&quot;PMID9185778&quot;&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name=&quot;PMID7853784&quot;&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Bei etwa 30 % der Erkrankungen lässt sich im Nachhinein der [[Infektionsweg]] nicht mehr nachvollziehen. Erhöhte Infektionsgefahr besteht heute für Konsumenten von Drogen wie [[Heroin]] und [[Kokain]] sowie bei Anbringung von [[Tätowierung]]en und [[Piercing]]s.  </div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Bei etwa 30 % der Erkrankungen lässt sich im Nachhinein der [[Infektionsweg]] nicht mehr nachvollziehen. Erhöhte Infektionsgefahr besteht heute für Konsumenten von Drogen wie [[Heroin]] und [[Kokain]] sowie bei Anbringung von [[Tätowierung]]en und [[Piercing]]s<ins style="font-weight: bold; text-decoration: none;">, die hierbei oft keine [[Hygiene]]standards eingehalten werden</ins>.  </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td></tr> </table>

Fmrauch https://ddn.pluspedia.org/w/index.php?title=Hepatitis_C&diff=722113&oldid=prev 2020-11-22T20:40:38Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 22. November 2020, 20:40 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''Hepatitis C''' ist eine durch das [[Hepatitis-C-Virus]] verursachte [[<del style="font-weight: bold; text-decoration: none;">Infektion</del>]]<del style="font-weight: bold; text-decoration: none;">skrankheit </del>beim Menschen. Sie zeichnet sich durch eine hohe Rate bei [[chronische Krankheit|chronischen Krankheitsverlauf]] aus (bis 80 %), die im Verlauf zu schweren [[Leber]]schädigungen wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. Die freien Übersichtsartikel zeigen 10 Jahre Forschungsgeschichte.&lt;ref name="PMID15084065"&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name="PMID15084064"&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name="PMID18519925"&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name="PMID8849151"&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name="PMID16923861"&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name="PMID19129320"&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name="PMID17699464"&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name="PMID17047105"&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name="PMID16905701"&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name="PMID16849345"&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name="PMID11413125"&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name="PMID9691933"&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name="PMID19034865"&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name="PMID10904508"&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name="PMID9690235"&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name="PMID17478492"&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name="PMID11261704"&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name="PMID11261703"&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name="PMID11261701"&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name="PMID11261700"&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name="PMID11261698"&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name="PMID11261697"&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name="PMID11261696"&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name="PMID15937203"&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name="PMID17317717"&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name="PMID12730523"&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name="PMID11584690"&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name="PMID1656611"&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name="PMID17552031"&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name="PMID17552030"&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name="PMID17552023"&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name="PMID18972443"&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name="PMID18972442"&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name="PMID18240152"&gt;Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name="PMID16941688"&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name="PMID16799966"&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name="PMID16149085"&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name="PMID15057920"&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name="PMID14752815"&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name="PMID12829979"&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name="PMID12407599"&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name="PMID12407590"&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name="PMID12407589"&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name="PMID12407588"&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name="PMID12407587"&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name="PMID12407578"&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name="PMID12407575"&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name="PMID11172332"&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name="PMID10733560"&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name="PMID9305659"&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name="PMID9185778"&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name="PMID7853784"&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''Hepatitis C''' ist eine durch das [[Hepatitis-C-Virus]] verursachte [[<ins style="font-weight: bold; text-decoration: none;">Infektionskrankheit</ins>]] beim Menschen. Sie zeichnet sich durch eine hohe Rate bei [[chronische Krankheit|chronischen Krankheitsverlauf]] aus (bis 80 %), die im Verlauf zu schweren [[Leber]]schädigungen wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. Die freien Übersichtsartikel zeigen 10 Jahre Forschungsgeschichte.&lt;ref name="PMID15084065"&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name="PMID15084064"&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name="PMID18519925"&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name="PMID8849151"&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name="PMID16923861"&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name="PMID19129320"&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name="PMID17699464"&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name="PMID17047105"&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name="PMID16905701"&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name="PMID16849345"&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name="PMID11413125"&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name="PMID9691933"&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name="PMID19034865"&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name="PMID10904508"&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name="PMID9690235"&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name="PMID17478492"&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name="PMID11261704"&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name="PMID11261703"&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name="PMID11261701"&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name="PMID11261700"&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name="PMID11261698"&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name="PMID11261697"&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name="PMID11261696"&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name="PMID15937203"&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name="PMID17317717"&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name="PMID12730523"&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name="PMID11584690"&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name="PMID1656611"&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name="PMID17552031"&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name="PMID17552030"&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name="PMID17552023"&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name="PMID18972443"&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name="PMID18972442"&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name="PMID18240152"&gt;Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name="PMID16941688"&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name="PMID16799966"&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name="PMID16149085"&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name="PMID15057920"&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name="PMID14752815"&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name="PMID12829979"&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name="PMID12407599"&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name="PMID12407590"&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name="PMID12407589"&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name="PMID12407588"&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name="PMID12407587"&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name="PMID12407578"&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name="PMID12407575"&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name="PMID11172332"&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name="PMID10733560"&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name="PMID9305659"&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name="PMID9185778"&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name="PMID7853784"&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Bei etwa 30 % der Erkrankungen lässt sich im Nachhinein der [[Infektionsweg]] nicht mehr nachvollziehen. Erhöhte Infektionsgefahr besteht heute für Konsumenten von Drogen wie [[Heroin]] und [[Kokain]] sowie bei Anbringung von [[Tätowierung]]en und [[Piercing]]s.  </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Bei etwa 30 % der Erkrankungen lässt sich im Nachhinein der [[Infektionsweg]] nicht mehr nachvollziehen. Erhöhte Infektionsgefahr besteht heute für Konsumenten von Drogen wie [[Heroin]] und [[Kokain]] sowie bei Anbringung von [[Tätowierung]]en und [[Piercing]]s.  </div></td></tr> </table>

Fmrauch https://ddn.pluspedia.org/w/index.php?title=Hepatitis_C&diff=722106&oldid=prev 2020-11-22T20:32:27Z

<p>weitere Ursachen</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 22. November 2020, 20:32 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&#039;&#039;&#039;Hepatitis C&#039;&#039;&#039; ist eine durch das [[Hepatitis-C-Virus]] verursachte [[Infektion]]skrankheit beim Menschen. Sie zeichnet sich durch eine hohe Rate bei [[chronische Krankheit|chronischen Krankheitsverlauf]] aus (bis 80 %), die im Verlauf zu schweren [[Leber]]schädigungen wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. Die freien Übersichtsartikel zeigen 10 Jahre Forschungsgeschichte.&lt;ref name=&quot;PMID15084065&quot;&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name=&quot;PMID15084064&quot;&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name=&quot;PMID18519925&quot;&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name=&quot;PMID8849151&quot;&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name=&quot;PMID16923861&quot;&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name=&quot;PMID19129320&quot;&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name=&quot;PMID17699464&quot;&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name=&quot;PMID17047105&quot;&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name=&quot;PMID16905701&quot;&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name=&quot;PMID16849345&quot;&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name=&quot;PMID11413125&quot;&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name=&quot;PMID9691933&quot;&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name=&quot;PMID19034865&quot;&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name=&quot;PMID10904508&quot;&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name=&quot;PMID9690235&quot;&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name=&quot;PMID17478492&quot;&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name=&quot;PMID11261704&quot;&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name=&quot;PMID11261703&quot;&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name=&quot;PMID11261701&quot;&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name=&quot;PMID11261700&quot;&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name=&quot;PMID11261698&quot;&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name=&quot;PMID11261697&quot;&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name=&quot;PMID11261696&quot;&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name=&quot;PMID15937203&quot;&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name=&quot;PMID17317717&quot;&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name=&quot;PMID12730523&quot;&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name=&quot;PMID11584690&quot;&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name=&quot;PMID1656611&quot;&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name=&quot;PMID17552031&quot;&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name=&quot;PMID17552030&quot;&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name=&quot;PMID17552023&quot;&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name=&quot;PMID18972443&quot;&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name=&quot;PMID18972442&quot;&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name=&quot;PMID18240152&quot;&gt;Hepatitis C genotype 4: What we know and what we don&#039;t yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name=&quot;PMID16941688&quot;&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name=&quot;PMID16799966&quot;&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name=&quot;PMID16149085&quot;&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name=&quot;PMID15057920&quot;&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name=&quot;PMID14752815&quot;&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name=&quot;PMID12829979&quot;&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name=&quot;PMID12407599&quot;&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name=&quot;PMID12407590&quot;&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name=&quot;PMID12407589&quot;&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name=&quot;PMID12407588&quot;&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name=&quot;PMID12407587&quot;&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name=&quot;PMID12407578&quot;&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name=&quot;PMID12407575&quot;&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name=&quot;PMID11172332&quot;&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name=&quot;PMID10733560&quot;&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name=&quot;PMID9305659&quot;&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name=&quot;PMID9185778&quot;&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name=&quot;PMID7853784&quot;&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&#039;&#039;&#039;Hepatitis C&#039;&#039;&#039; ist eine durch das [[Hepatitis-C-Virus]] verursachte [[Infektion]]skrankheit beim Menschen. Sie zeichnet sich durch eine hohe Rate bei [[chronische Krankheit|chronischen Krankheitsverlauf]] aus (bis 80 %), die im Verlauf zu schweren [[Leber]]schädigungen wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. Die freien Übersichtsartikel zeigen 10 Jahre Forschungsgeschichte.&lt;ref name=&quot;PMID15084065&quot;&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name=&quot;PMID15084064&quot;&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name=&quot;PMID18519925&quot;&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name=&quot;PMID8849151&quot;&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name=&quot;PMID16923861&quot;&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name=&quot;PMID19129320&quot;&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name=&quot;PMID17699464&quot;&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name=&quot;PMID17047105&quot;&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name=&quot;PMID16905701&quot;&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name=&quot;PMID16849345&quot;&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name=&quot;PMID11413125&quot;&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name=&quot;PMID9691933&quot;&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name=&quot;PMID19034865&quot;&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name=&quot;PMID10904508&quot;&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name=&quot;PMID9690235&quot;&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name=&quot;PMID17478492&quot;&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name=&quot;PMID11261704&quot;&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name=&quot;PMID11261703&quot;&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name=&quot;PMID11261701&quot;&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name=&quot;PMID11261700&quot;&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name=&quot;PMID11261698&quot;&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name=&quot;PMID11261697&quot;&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name=&quot;PMID11261696&quot;&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name=&quot;PMID15937203&quot;&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name=&quot;PMID17317717&quot;&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name=&quot;PMID12730523&quot;&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name=&quot;PMID11584690&quot;&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name=&quot;PMID1656611&quot;&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name=&quot;PMID17552031&quot;&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name=&quot;PMID17552030&quot;&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name=&quot;PMID17552023&quot;&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name=&quot;PMID18972443&quot;&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name=&quot;PMID18972442&quot;&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name=&quot;PMID18240152&quot;&gt;Hepatitis C genotype 4: What we know and what we don&#039;t yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name=&quot;PMID16941688&quot;&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name=&quot;PMID16799966&quot;&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name=&quot;PMID16149085&quot;&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name=&quot;PMID15057920&quot;&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name=&quot;PMID14752815&quot;&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name=&quot;PMID12829979&quot;&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name=&quot;PMID12407599&quot;&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name=&quot;PMID12407590&quot;&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name=&quot;PMID12407589&quot;&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name=&quot;PMID12407588&quot;&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name=&quot;PMID12407587&quot;&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name=&quot;PMID12407578&quot;&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name=&quot;PMID12407575&quot;&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name=&quot;PMID11172332&quot;&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name=&quot;PMID10733560&quot;&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name=&quot;PMID9305659&quot;&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name=&quot;PMID9185778&quot;&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name=&quot;PMID7853784&quot;&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Bei etwa 30 % der Erkrankungen lässt sich im Nachhinein der [[Infektionsweg]] nicht mehr nachvollziehen. Erhöhte Infektionsgefahr besteht heute für Konsumenten von Drogen wie [[Heroin]] und [[Kokain]] sowie bei Anbringung von [[Tätowierung]]en und [[Piercing]]s. </ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td></tr> </table>

Fmrauch https://ddn.pluspedia.org/w/index.php?title=Hepatitis_C&diff=722103&oldid=prev 2020-11-22T20:23:34Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 22. November 2020, 20:23 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''Hepatitis C''' ist eine durch das [[Hepatitis-C-Virus]] verursachte [[Infektion]]skrankheit beim Menschen. Sie zeichnet sich durch eine hohe Rate <del style="font-weight: bold; text-decoration: none;">der </del>[[<del style="font-weight: bold; text-decoration: none;">Chronifizierung</del>]] aus (bis 80 %), die im Verlauf zu schweren <del style="font-weight: bold; text-decoration: none;">Leberschädigungen </del>wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. <del style="font-weight: bold; text-decoration: none;">Freie </del>Übersichtsartikel zeigen <del style="font-weight: bold; text-decoration: none;">die </del>Forschungsgeschichte.&lt;ref name="PMID15084065"&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name="PMID15084064"&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name="PMID18519925"&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name="PMID8849151"&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name="PMID16923861"&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name="PMID19129320"&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name="PMID17699464"&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name="PMID17047105"&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name="PMID16905701"&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name="PMID16849345"&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name="PMID11413125"&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name="PMID9691933"&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name="PMID19034865"&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name="PMID10904508"&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name="PMID9690235"&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name="PMID17478492"&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name="PMID11261704"&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name="PMID11261703"&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name="PMID11261701"&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name="PMID11261700"&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name="PMID11261698"&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name="PMID11261697"&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name="PMID11261696"&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name="PMID15937203"&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name="PMID17317717"&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name="PMID12730523"&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name="PMID11584690"&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name="PMID1656611"&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name="PMID17552031"&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name="PMID17552030"&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name="PMID17552023"&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name="PMID18972443"&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name="PMID18972442"&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name="PMID18240152"&gt;Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name="PMID16941688"&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name="PMID16799966"&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name="PMID16149085"&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name="PMID15057920"&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name="PMID14752815"&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name="PMID12829979"&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name="PMID12407599"&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name="PMID12407590"&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name="PMID12407589"&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name="PMID12407588"&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name="PMID12407587"&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name="PMID12407578"&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name="PMID12407575"&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name="PMID11172332"&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name="PMID10733560"&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name="PMID9305659"&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name="PMID9185778"&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name="PMID7853784"&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''Hepatitis C''' ist eine durch das [[Hepatitis-C-Virus]] verursachte [[Infektion]]skrankheit beim Menschen. Sie zeichnet sich durch eine hohe Rate <ins style="font-weight: bold; text-decoration: none;">bei </ins>[[<ins style="font-weight: bold; text-decoration: none;">chronische Krankheit|chronischen Krankheitsverlauf</ins>]] aus (bis 80 %), die im Verlauf zu schweren <ins style="font-weight: bold; text-decoration: none;">[[Leber]]schädigungen </ins>wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. <ins style="font-weight: bold; text-decoration: none;">Die freien </ins>Übersichtsartikel zeigen <ins style="font-weight: bold; text-decoration: none;">10 Jahre </ins>Forschungsgeschichte.&lt;ref name="PMID15084065"&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name="PMID15084064"&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name="PMID18519925"&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name="PMID8849151"&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name="PMID16923861"&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name="PMID19129320"&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name="PMID17699464"&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name="PMID17047105"&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name="PMID16905701"&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name="PMID16849345"&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name="PMID11413125"&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name="PMID9691933"&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name="PMID19034865"&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name="PMID10904508"&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name="PMID9690235"&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name="PMID17478492"&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name="PMID11261704"&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name="PMID11261703"&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name="PMID11261701"&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name="PMID11261700"&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name="PMID11261698"&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name="PMID11261697"&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name="PMID11261696"&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name="PMID15937203"&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name="PMID17317717"&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name="PMID12730523"&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name="PMID11584690"&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name="PMID1656611"&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name="PMID17552031"&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name="PMID17552030"&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name="PMID17552023"&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name="PMID18972443"&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name="PMID18972442"&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name="PMID18240152"&gt;Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name="PMID16941688"&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name="PMID16799966"&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name="PMID16149085"&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name="PMID15057920"&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name="PMID14752815"&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name="PMID12829979"&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name="PMID12407599"&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name="PMID12407590"&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name="PMID12407589"&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name="PMID12407588"&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name="PMID12407587"&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name="PMID12407578"&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name="PMID12407575"&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name="PMID11172332"&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name="PMID10733560"&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name="PMID9305659"&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name="PMID9185778"&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name="PMID7853784"&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td></tr> </table>

Fmrauch https://ddn.pluspedia.org/w/index.php?title=Hepatitis_C&diff=722102&oldid=prev 2020-11-22T20:21:36Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 22. November 2020, 20:21 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''<ins style="font-weight: bold; text-decoration: none;">Hepatitis C</ins>''' <ins style="font-weight: bold; text-decoration: none;">ist eine durch das [[Hepatitis-C</ins>-<ins style="font-weight: bold; text-decoration: none;">Virus]] verursachte [[Infektion]]skrankheit beim Menschen. Sie zeichnet sich durch eine hohe Rate der [[Chronifizierung]] aus (bis 80 %), die im Verlauf zu schweren Leberschädigungen wie der [[Leberzirrhose]] und dem [[Leberzellkarzinom]] führen kann. </ins>Freie Übersichtsartikel <ins style="font-weight: bold; text-decoration: none;">zeigen die Forschungsgeschichte.&lt;ref </ins>name="PMID15084065"&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name="PMID15084064"&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name="PMID18519925"&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name="PMID8849151"&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name="PMID16923861"&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name="PMID19129320"&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name="PMID17699464"&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name="PMID17047105"&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name="PMID16905701"&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name="PMID16849345"&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name="PMID11413125"&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name="PMID9691933"&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name="PMID19034865"&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name="PMID10904508"&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name="PMID9690235"&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name="PMID17478492"&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name="PMID11261704"&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name="PMID11261703"&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name="PMID11261701"&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name="PMID11261700"&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name="PMID11261698"&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name="PMID11261697"&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name="PMID11261696"&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name="PMID15937203"&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name="PMID17317717"&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name="PMID12730523"&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name="PMID11584690"&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name="PMID1656611"&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name="PMID17552031"&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name="PMID17552030"&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name="PMID17552023"&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name="PMID18972443"&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name="PMID18972442"&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name="PMID18240152"&gt;Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name="PMID16941688"&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name="PMID16799966"&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name="PMID16149085"&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name="PMID15057920"&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name="PMID14752815"&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name="PMID12829979"&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name="PMID12407599"&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name="PMID12407590"&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name="PMID12407589"&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name="PMID12407588"&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name="PMID12407587"&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name="PMID12407578"&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name="PMID12407575"&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name="PMID11172332"&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name="PMID10733560"&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name="PMID9305659"&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name="PMID9185778"&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name="PMID7853784"&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">{| class="wikitable" |</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | </del>'''<del style="font-weight: bold; text-decoration: none;">Siehe auch</del>'''</div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800" |</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|</del>-</div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''</del>Freie Übersichtsartikel<del style="font-weight: bold; text-decoration: none;">'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800" |&lt;ref </del>name="PMID15084065"&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name="PMID15084064"&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name="PMID18519925"&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name="PMID8849151"&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name="PMID16923861"&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name="PMID19129320"&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name="PMID17699464"&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name="PMID17047105"&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name="PMID16905701"&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name="PMID16849345"&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name="PMID11413125"&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name="PMID9691933"&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name="PMID19034865"&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name="PMID10904508"&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name="PMID9690235"&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name="PMID17478492"&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name="PMID11261704"&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name="PMID11261703"&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name="PMID11261701"&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name="PMID11261700"&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name="PMID11261698"&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name="PMID11261697"&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name="PMID11261696"&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name="PMID15937203"&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name="PMID17317717"&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name="PMID12730523"&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name="PMID11584690"&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name="PMID1656611"&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name="PMID17552031"&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name="PMID17552030"&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name="PMID17552023"&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name="PMID18972443"&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name="PMID18972442"&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name="PMID18240152"&gt;Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name="PMID16941688"&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name="PMID16799966"&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name="PMID16149085"&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name="PMID15057920"&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name="PMID14752815"&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name="PMID12829979"&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name="PMID12407599"&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name="PMID12407590"&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name="PMID12407589"&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name="PMID12407588"&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name="PMID12407587"&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name="PMID12407578"&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name="PMID12407575"&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name="PMID11172332"&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name="PMID10733560"&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name="PMID9305659"&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name="PMID9185778"&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name="PMID7853784"&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;</div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Medline Suchterm/ Synonyme'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#00dfdf" | '''Was ist das'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Struktur'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Physiologie'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Knockout'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Transgen'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Mutation'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Polymorphismus'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Genexpression'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Inhibitoren'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|-</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| bgcolor="#dfdfdf" | '''Agonisten'''</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">| align="left" width="800"| </del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">|}</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">----</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td></tr> </table>

Fmrauch https://ddn.pluspedia.org/w/index.php?title=Hepatitis_C&diff=722101&oldid=prev 2020-11-22T20:18:56Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 22. November 2020, 20:18 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l49">Zeile 49:</td> <td colspan="2" class="diff-lineno">Zeile 49:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;references /&gt;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;references /&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{PPA-Kupfer}}</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>{{<del style="font-weight: bold; text-decoration: none;">LinkWP_Miniartikel</del>|<del style="font-weight: bold; text-decoration: none;">Txt</del>=<del style="font-weight: bold; text-decoration: none;">Hepatitis C</del>|<del style="font-weight: bold; text-decoration: none;">Link</del>=<del style="font-weight: bold; text-decoration: none;">Hepatitis C</del>}}</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>{{<ins style="font-weight: bold; text-decoration: none;">Gesundheitshinweis}}</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{Normdaten</ins>|<ins style="font-weight: bold; text-decoration: none;">TYP</ins>=<ins style="font-weight: bold; text-decoration: none;">s</ins>|<ins style="font-weight: bold; text-decoration: none;">GND</ins>=<ins style="font-weight: bold; text-decoration: none;">4262007-7</ins>}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Kategorie:Virale Infektionskrankheit des Menschen]]</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Kategorie:Krankheitsbild in der Gastroenterologie]]</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Kategorie:Meldepflichtige Krankheit]]</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Kategorie:Hepatologie]]</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[Kategorie:Sexuell übertragbare Erkrankung]]</ins></div></td></tr> </table>

Fmrauch https://ddn.pluspedia.org/w/index.php?title=Hepatitis_C&diff=40433&oldid=prev 2010-04-03T16:31:00Z

<p>Die Seite wurde neu angelegt: „<a href="/wiki/Datei:Pptpdtjpg1.png" title="Datei:Pptpdtjpg1.png">miniatur|Entstehender Artikel</a> {| class=&quot;wikitable&quot; | | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039; | align=&quot;left&quot; width=&quot;800&quot; | |- | bgcolor=&quot;#d…“</p> <p><b>Neue Seite</b></p><div>[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]<br /> {| class=&quot;wikitable&quot; |<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot; |<br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Freie Übersichtsartikel&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot; |&lt;ref name=&quot;PMID15084065&quot;&gt;Managing hepatitis C. Am J Manag Care 10(2 Suppl):S30-40 (2004) PMID 15084065 &lt;/ref&gt;&lt;ref name=&quot;PMID15084064&quot;&gt;Understanding hepatitis C. Am J Manag Care 10(2 Suppl):S21-9 (2004) PMID 15084064 &lt;/ref&gt;&lt;ref name=&quot;PMID18519925&quot;&gt;In the clinic. Hepatitis C. Ann Intern Med 148(11):ITC6-1-ITC6-16 (2008) PMID 18519925 &lt;/ref&gt;&lt;ref name=&quot;PMID8849151&quot;&gt;Hepatitis C. Ann Intern Med 125(8):658-68 (1996) PMID 8849151 &lt;/ref&gt;&lt;ref name=&quot;PMID16923861&quot;&gt;Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91(9):781-5 (2006) PMID 16923861 &lt;/ref&gt;&lt;ref name=&quot;PMID19129320&quot;&gt;Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4(1):207-20 (2009) PMID 19129320 &lt;/ref&gt;&lt;ref name=&quot;PMID17699464&quot;&gt;The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2(3):563-75 (2007) PMID 17699464 &lt;/ref&gt;&lt;ref name=&quot;PMID17047105&quot;&gt;Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition? Gut 55(11):1535-7 (2006) PMID 17047105 &lt;/ref&gt;&lt;ref name=&quot;PMID16905701&quot;&gt;Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55(9):1350-9 (2006) PMID 16905701 &lt;/ref&gt;&lt;ref name=&quot;PMID16849345&quot;&gt;Acute hepatitis C virus infection: a neglected disease? Gut 55(8):1075-7 (2006) PMID 16849345 &lt;/ref&gt;&lt;ref name=&quot;PMID11413125&quot;&gt;Clinical guidelines on the management of hepatitis C. Gut 49 Suppl 1():I1-21 (2001) PMID 11413125 &lt;/ref&gt;&lt;ref name=&quot;PMID9691933&quot;&gt;French consensus conference on hepatitis C: screening and treatment. Gut 42(6):892-8 (1998) PMID 9691933 &lt;/ref&gt;&lt;ref name=&quot;PMID19034865&quot;&gt;Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 21(6):813-25 (2008) PMID 19034865 &lt;/ref&gt;&lt;ref name=&quot;PMID10904508&quot;&gt;The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284(4):450-6 (2000) PMID 10904508 &lt;/ref&gt;&lt;ref name=&quot;PMID9690235&quot;&gt;Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54(2):650-71 (1998) PMID 9690235 &lt;/ref&gt;&lt;ref name=&quot;PMID17478492&quot;&gt;Hepatitis C virus: from entry to renal injury--facts and potentials. Nephrol Dial Transplant 22(7):1840-8 (2007) PMID 17478492 &lt;/ref&gt;&lt;ref name=&quot;PMID11261704&quot;&gt;Treatment of hepatitis C virus infection in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():46-8 (2000) PMID 11261704 &lt;/ref&gt;&lt;ref name=&quot;PMID11261703&quot;&gt;Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15 Suppl 8():42-5 (2000) PMID 11261703 &lt;/ref&gt;&lt;ref name=&quot;PMID11261701&quot;&gt;Treatment of glomerulonephritides associated with hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():34-8 (2000) PMID 11261701 &lt;/ref&gt;&lt;ref name=&quot;PMID11261700&quot;&gt;Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15 Suppl 8():28-33 (2000) PMID 11261700 &lt;/ref&gt;&lt;ref name=&quot;PMID11261698&quot;&gt;Hepatitis C. Nephrol Dial Transplant 15 Suppl 8():2-11 (2000) PMID 11261698 &lt;/ref&gt;&lt;ref name=&quot;PMID11261697&quot;&gt;The natural history of hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():19-23 (2000) PMID 11261697 &lt;/ref&gt;&lt;ref name=&quot;PMID11261696&quot;&gt;Diagnostic tests for hepatitis C virus infection. Nephrol Dial Transplant 15 Suppl 8():15-8 (2000) PMID 11261696 &lt;/ref&gt;&lt;ref name=&quot;PMID15937203&quot;&gt;Management of chronic hepatitis C. Postgrad Med J 81(956):376-82 (2005) PMID 15937203 &lt;/ref&gt;&lt;ref name=&quot;PMID17317717&quot;&gt;Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46(4):572-8 (2007) PMID 17317717 &lt;/ref&gt;&lt;ref name=&quot;PMID12730523&quot;&gt;Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 42(7):818-28 (2003) PMID 12730523 &lt;/ref&gt;&lt;ref name=&quot;PMID11584690&quot;&gt;Hepatitis C: an update. Swiss Med Wkly 131(21-22):291-8 (2001) PMID 11584690 &lt;/ref&gt;&lt;ref name=&quot;PMID1656611&quot;&gt;Hepatitis C virus. A review. West J Med 155(2):164-8 (1991) PMID 1656611 &lt;/ref&gt;&lt;ref name=&quot;PMID17552031&quot;&gt;Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13(17):2467-78 (2007) PMID 17552031 &lt;/ref&gt;&lt;ref name=&quot;PMID17552030&quot;&gt;Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461-6 (2007) PMID 17552030 &lt;/ref&gt;&lt;ref name=&quot;PMID17552023&quot;&gt;Hepatitis C virus proteins. World J Gastroenterol 13(17):2406-15 (2007) PMID 17552023 &lt;/ref&gt;&lt;ref name=&quot;PMID18972443&quot;&gt;Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection. Hepatology 48(5):1700-12 (2008) PMID 18972443 &lt;/ref&gt;&lt;ref name=&quot;PMID18972442&quot;&gt;Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48(5):1690-9 (2008) PMID 18972442 &lt;/ref&gt;&lt;ref name=&quot;PMID18240152&quot;&gt;Hepatitis C genotype 4: What we know and what we don&#039;t yet know. Hepatology 47(4):1371-83 (2008) PMID 18240152 &lt;/ref&gt;&lt;ref name=&quot;PMID16941688&quot;&gt;Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44(3):527-35 (2006) PMID 16941688 &lt;/ref&gt;&lt;ref name=&quot;PMID16799966&quot;&gt;Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44(1):15-22 (2006) PMID 16799966 &lt;/ref&gt;&lt;ref name=&quot;PMID16149085&quot;&gt;Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962-73 (2005) PMID 16149085 &lt;/ref&gt;&lt;ref name=&quot;PMID15057920&quot;&gt;Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147-71 (2004) PMID 15057920 &lt;/ref&gt;&lt;ref name=&quot;PMID14752815&quot;&gt;Structural biology of hepatitis C virus. Hepatology 39(1):5-19 (2004) PMID 14752815 &lt;/ref&gt;&lt;ref name=&quot;PMID12829979&quot;&gt;Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 &lt;/ref&gt;&lt;ref name=&quot;PMID12407599&quot;&gt;Side effects of therapy of hepatitis C and their management. Hepatology 36(5 Suppl 1):S237-44 (2002) PMID 12407599 &lt;/ref&gt;&lt;ref name=&quot;PMID12407590&quot;&gt;Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S161-72 (2002) PMID 12407590 &lt;/ref&gt;&lt;ref name=&quot;PMID12407589&quot;&gt;The role of liver biopsy in chronic hepatitis C. Hepatology 36(5 Suppl 1):S152-60 (2002) PMID 12407589 &lt;/ref&gt;&lt;ref name=&quot;PMID12407588&quot;&gt;Monitoring of viral levels during therapy of hepatitis C. Hepatology 36(5 Suppl 1):S145-51 (2002) PMID 12407588 &lt;/ref&gt;&lt;ref name=&quot;PMID12407587&quot;&gt;Treatment of chronic hepatitis C: a systematic review. Hepatology 36(5 Suppl 1):S135-44 (2002) PMID 12407587 &lt;/ref&gt;&lt;ref name=&quot;PMID12407578&quot;&gt;Use and interpretation of virological tests for hepatitis C. Hepatology 36(5 Suppl 1):S65-73 (2002) PMID 12407578 &lt;/ref&gt;&lt;ref name=&quot;PMID12407575&quot;&gt;Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35-46 (2002) PMID 12407575 &lt;/ref&gt;&lt;ref name=&quot;PMID11172332&quot;&gt;Acute hepatitis C. Hepatology 33(2):321-7 (2001) PMID 11172332 &lt;/ref&gt;&lt;ref name=&quot;PMID10733560&quot;&gt;Natural history of hepatitis C: its impact on clinical management. Hepatology 31(4):1014-8 (2000) PMID 10733560 &lt;/ref&gt;&lt;ref name=&quot;PMID9305659&quot;&gt;Natural history of hepatitis C. Hepatology 26(3 Suppl 1):21S-28S (1997) PMID 9305659 &lt;/ref&gt;&lt;ref name=&quot;PMID9185778&quot;&gt;The molecular virology of hepatitis C. Hepatology 25(6):1527-38 (1997) PMID 9185778 &lt;/ref&gt;&lt;ref name=&quot;PMID7853784&quot;&gt;Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255-63 (1994) PMID 7853784 &lt;/ref&gt;<br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Wichtige Übersichtsartikel&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Medline Suchterm/ Synonyme&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#00dfdf&quot; | &#039;&#039;&#039;Was ist das&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Struktur&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Physiologie&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Knockout&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Transgen&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Mutation&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Polymorphismus&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Genexpression&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Inhibitoren&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Agonisten&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |}<br /> <br /> ----<br /> <br /> == Bibliographie ==<br /> &lt;references /&gt;<br /> <br /> <br /> {{LinkWP_Miniartikel|Txt=Hepatitis C|Link=Hepatitis C}}</div>

Ossip Groth